Log In
Print this Print this


Also known as: 1278863

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSmall molecule prolyl hydroxylase inhibitor
Molecular Target Prolyl 4-hydroxylase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat anemia associated with chronic kidney disease (CKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today